Multiple Sclerosis Discovery Forum

Inspiring Connections

Most Viewed

Microvesicles: novel biomarkers for neurological disorders.
Discovery of fingolimod, the sphingosine 1-phosphate receptor modulator and its application for the therapy of multiple sclerosis.
Visual dysfunction in multiple sclerosis correlates better with optical coherence tomography derived estimates of macular ganglion cell layer thickness than peripapillary retinal nerve fiber layer thickness.
Cancer risk in multiple sclerosis: findings from British Columbia, Canada.
Benign Multiple Sclerosis: Does it exist?
Lodonal/LDN
Synthon obtains approval for glatiramer acetate 20 mg/mL in Europe
Cyclophosphamide modulates CD4+ T cells into a T helper type 2 phenotype and reverses increased IFN-gamma production of CD8+ T cells in secondary progressive multiple sclerosis.
Nerve Conduction Velocity Is Regulated by the Inositol Polyphosphate-4-Phosphatase II Gene.
Psychotherapeutic and psychosocial interventions for managing stress in multiple sclerosis: the contribution of mindfulness-based interventions.
Genmab collaborator GSK starts new ofatumumab Phase III study in rare skin disorder
Low-contrast visual tests reveal better alemtuzumab efficacy
Stabilization of rapidly worsening multiple sclerosis for 36 months in patients treated with interferon beta plus cyclophosphamide followed by interferon beta.
Group exercise training for balance, functional status, spasticity, fatigue and quality of life in multiple sclerosis: a randomized controlled trial.
Mapi Pharma granted United States patent covering glatiramer depot for multiple sclerosis
An observational comparison of natalizumab vs. fingolimod using JCV serology to determine therapy.
Concurrent saturation transfer contrast in in vivo brain by a uniform magnetization transfer MRI.
A Randomized Placebo-Controlled, Crossover-Design Study of the Effects of Low Dose Naltrexone
The effects of intrathecal rituximab on biomarkers in multiple sclerosis.
Eicosapentaenoic acid (EPA) induces peroxisome proliferator-activated receptors and ameliorates experimental autoimmune encephalomyelitis.
DemTect, PANDA, EASY, and MUSIC: Cognitive Screening Tools with Age Correction and Weighting of Subtests According to Their Sensitivity and Specificity.
The ketogenic diet as a treatment paradigm for diverse neurological disorders.
Validity and Reliability of a Persian Translation of the Minimal Assessment of Cognitive Function in Multiple Sclerosis (MACFIMS).
Acute disseminated encephalomyelitis--a prospective study of clinical profile and in-hospital outcome predictors.
A major histocompatibility Class I locus contributes to multiple sclerosis susceptibility independently from HLA-DRB1*15:01.

Pages